[1] Khalilullah H., Ahsan, J.M., Hedaitullah M., Khan S.; Ahmed B., 1, 3, 4-oxadiazole: a Biologically Active Scaffold, Mini Reviews in Medicinal Chemistry.,12: 789-801 (2012).
[2] Shakir R.M., Ariffin A., Abdulla M.A., Synthesis of New 2, 5-di-substituted 1, 3, 4-oxadiazoles Bearing 2, 6-di-tert-butylphenol Moieties and Evaluation of their Antioxidant Activity, Molecules., 19: 3436-3449 (2014).
[3] Alp A.S., Kilcigıl, G.; Özdamar E.D., ÇOBAN T., Eke B., Synthesis and Evaluation of Antioxidant Activities of Novel 1, 3, 4-oxadiazole and Imine Containing 1H Benzimid-Azoles, Turkish Journal of Chemistry., 39: 42-53 (2015).
[4] Suresh D.B., Jamatsing D.R., Pravin S.K., Ratnamala S.B., Synthesis, Characterization and Antioxidant Activity of Carvacrol Containing Novel Thiadiazole and Oxadiazole Moieties. Mod. Chem. Appl., 4: 1-4 (2016).
[5] Patrao P., Khader A.M.A., Kalluraya B., Synthesis of New 5-Naphthyl Substituted 1, 3, 4-Oxadiazole Derivatives and their Antioxidant Activity, Der. Pharm Chem., 5: 24-32(2013).
[6] Grewal A.S., Redhu S., Synthesis, Antibacterial and Antifungal Activity of 2, 5-Disubstituted-1, 3, 4-oxadiazole Derivatives, Pharm. Tech. Res., 6: 2015-2021 (2014).
[7] Selvakumar B., Vaidyanathan S.P., Madhuri S., Elango K.P., Synthesis and Antiviral Activity of Sulfonohydrazide and 1, 3, 4-oxadiazole Derivatives of 6, 6-dimethyl-9-oxo-4, 5, 6, 7, 8, 9-Hexahydropyrazolo [5, 1-b] Quinazoline, Journal of Chemical Research, 41: 221-224 (2017).
[8] Parikh P.K., Marvaniya H.M., Sen D.J., Synthesis and Biological Evaluation of 1, 3, 4-oxadiazole Derivatives as Potential Antibacterial and Antifungal Agents, Int. J. Drug Dev. & Res., 3: 248-255 (2011).
[9] Özdemir A., Sever B., Altıntop M.D., Temel H.E., Atlı Ö., Baysal M., Demirci F., Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9, Molecules, 22: 1109- (2017).
[10] Bondock S., Adel S., Etman H.A., Badria F.A., Synthesis and Antitumor Evaluation of Some New 1, 3, 4-oxadiazole-based Heterocycles, European Journal of Medicinal Chemistry, 48: 192-199 (2012).
[11] Singh A.K., Lohani M., Parthsarthy R., Synthesis, Characterization and Anti-Inflammatory Activity of Some 1, 3,4 -Oxadiazole Derivatives, IJPR , 12: 319-323 (2013).
[12] Shyma P.C., Kalluraya B., SK P., AM V., Synthesis, Characterization, Antidiabetic and Antioxidant Activity of 1, 3, 4-oxadiazole Derivatives Bearing 6-Methyl Pyridine Moiety, Der. Pharm. Chemica, 7: 137-45(2015).
[13] El-Sadek M.M., Hassan S.Y., El-Dayem N.S., Yacout G.A., 5-(5-Aryl-1, 3, 4-oxadiazole-2-carbonyl) Furan-3-carboxylate and New Cyclic C-Glycoside Analogues from Carbohydrate Precursors with MAO-B, Antimicrobial and Antifungal Activities, Molecules, 17: 7010-7027 (2012).
[14] A.Gómez Sánchez and A. Rodríguez Roldán, Carbohydr.Res., 22: 53-62 (1972).
[15] Guthrie R.D., Honeyman J., Chem. and Industry, I: 557-562 (1958).
[16] John W.Rowen, Florence H. Forziati and Richard E.Reeves, J. Chem. Soc., 20: 1697 (1951).
[17] Alexandrou, N.E. Reassignment of Structures of the Dihydro-v-Tetrazines. II: Mechanism of Oxidation of Diacylhydrazones, Tetrahedron, 22: 1309–1316 (1966).
[18] El Khadem H., Shaban M.A.E., Carbohydrate Derivatives of 1-substituted 1,2,3-triazoles, J. Chem. Soc., 1967: 519–520(1967).
[19] El-Khadem, H.; Shaban, M.A.E.; Nassr, M.A.M. Oxidation of mesoxalaldehyde bis- and tris-(benzoylhydrazones). J. Chem. Soc.,1969, p. 1416–1418(1969).
[20] El-Khadem H., El-Sadik M.M., Meshreki M.H., Reactions of Phenylglyoxal Bisarylhydrazones, J. Chem. Soc., 1968: 2097–2099(1968).
[21] Burns J.L., Van Dalfsen J.M., Shawar R.M., Otto K.L., Garber R.L., Quan J.M., Smith A.L., Journal of Infectious Diseases, 179: 1190-1196(1999).